
Michael P Barker
Examiner (ID: 6725, Phone: (571)272-0303 , Office: P/1626 )
| Most Active Art Unit | 1626 |
| Art Unit(s) | 1655, OPQA, 1626 |
| Total Applications | 1330 |
| Issued Applications | 1017 |
| Pending Applications | 61 |
| Abandoned Applications | 256 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10548466
[patent_doc_number] => 09273078
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-01
[patent_title] => 'Half-phthalocyanine-like chelates and synthesis thereof'
[patent_app_type] => utility
[patent_app_number] => 14/561955
[patent_app_country] => US
[patent_app_date] => 2014-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6106
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14561955
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/561955 | Half-phthalocyanine-like chelates and synthesis thereof | Dec 4, 2014 | Issued |
Array
(
[id] => 11350158
[patent_doc_number] => 20160368898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-22
[patent_title] => '2-PYRIDYLOXY-4-METHYL OREXIN RECEPTOR ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 15/103079
[patent_app_country] => US
[patent_app_date] => 2014-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13514
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15103079
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/103079 | 2-pyridyloxy-4-methyl orexin receptor antagonists | Dec 3, 2014 | Issued |
Array
(
[id] => 12044480
[patent_doc_number] => 09822069
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-21
[patent_title] => 'Urea derivative or pharmacologically acceptable salt thereof'
[patent_app_type] => utility
[patent_app_number] => 15/039964
[patent_app_country] => US
[patent_app_date] => 2014-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 97410
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15039964
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/039964 | Urea derivative or pharmacologically acceptable salt thereof | Nov 26, 2014 | Issued |
Array
(
[id] => 14356445
[patent_doc_number] => 10299500
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Granules of protein-rich microalgal biomass flour and method for preparing same
[patent_app_type] => utility
[patent_app_number] => 15/039868
[patent_app_country] => US
[patent_app_date] => 2014-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9615
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15039868
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/039868 | Granules of protein-rich microalgal biomass flour and method for preparing same | Nov 26, 2014 | Issued |
Array
(
[id] => 12165327
[patent_doc_number] => 09884086
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-06
[patent_title] => 'Administration method for anticancer drugs'
[patent_app_type] => utility
[patent_app_number] => 14/551088
[patent_app_country] => US
[patent_app_date] => 2014-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 22
[patent_no_of_words] => 8328
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14551088
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/551088 | Administration method for anticancer drugs | Nov 23, 2014 | Issued |
Array
(
[id] => 11364027
[patent_doc_number] => 20170002008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-05
[patent_title] => 'BICYCLOAMINE-SUBSTITUTED-N-BENZENESULFONAMIDE COMPOUNDS WITH SELECTIVE ACTIVITY IN VOLTAGE-GATED SODIUM CHANNELS'
[patent_app_type] => utility
[patent_app_number] => 15/038805
[patent_app_country] => US
[patent_app_date] => 2014-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50683
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15038805
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/038805 | Bicycloamine-substituted-N-benzenesulfonamide compounds with selective activity in voltage-gated sodium channels | Nov 23, 2014 | Issued |
Array
(
[id] => 10186760
[patent_doc_number] => 09216168
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2015-12-22
[patent_title] => 'Therapeutic compositions comprising imidazole and imidazolium compounds'
[patent_app_type] => utility
[patent_app_number] => 14/540333
[patent_app_country] => US
[patent_app_date] => 2014-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13017
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14540333
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/540333 | Therapeutic compositions comprising imidazole and imidazolium compounds | Nov 12, 2014 | Issued |
Array
(
[id] => 11507220
[patent_doc_number] => 09598365
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-21
[patent_title] => 'Method for synthesizing cycloalkanyl[b]indoles, cycloalkanyl[b]benzofurans, cycloalkanyl[b]benzothiophenes, compounds and methods of use'
[patent_app_type] => utility
[patent_app_number] => 14/537154
[patent_app_country] => US
[patent_app_date] => 2014-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10204
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14537154
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/537154 | Method for synthesizing cycloalkanyl[b]indoles, cycloalkanyl[b]benzofurans, cycloalkanyl[b]benzothiophenes, compounds and methods of use | Nov 9, 2014 | Issued |
Array
(
[id] => 10279880
[patent_doc_number] => 20150164876
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-18
[patent_title] => 'COMPOUNDS AND METHODS FOR INHIBITING PHOSPHATE TRANSPORT'
[patent_app_type] => utility
[patent_app_number] => 14/536509
[patent_app_country] => US
[patent_app_date] => 2014-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 135906
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14536509
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/536509 | Compounds and methods for inhibiting phosphate transport | Nov 6, 2014 | Issued |
Array
(
[id] => 15913041
[patent_doc_number] => 10653742
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => Anti-inflammatory use of liquid phytocomplexes from olive
[patent_app_type] => utility
[patent_app_number] => 15/033589
[patent_app_country] => US
[patent_app_date] => 2014-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 8157
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15033589
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/033589 | Anti-inflammatory use of liquid phytocomplexes from olive | Oct 30, 2014 | Issued |
Array
(
[id] => 16831013
[patent_doc_number] => 11007244
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-18
[patent_title] => Soluble, stable, anti-inflammatory, proliferative, protective and mucoadhesive pharmaceutical compositions; use thereof for treating mucositis conditions and method for producing same; base pharmaceutical composition for preparing the pharmaceutical compositions and method for producing same
[patent_app_type] => utility
[patent_app_number] => 15/522763
[patent_app_country] => US
[patent_app_date] => 2014-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 7654
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15522763
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/522763 | Soluble, stable, anti-inflammatory, proliferative, protective and mucoadhesive pharmaceutical compositions; use thereof for treating mucositis conditions and method for producing same; base pharmaceutical composition for preparing the pharmaceutical compositions and method for producing same | Oct 26, 2014 | Issued |
Array
(
[id] => 11499122
[patent_doc_number] => 20170073307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'CRYSTAL FORM III OF (S)-OXIRACETAM, PREPARATION METHOD AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/122567
[patent_app_country] => US
[patent_app_date] => 2014-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3925
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15122567
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/122567 | Crystal form III of (S)-oxiracetam, preparation method and use thereof | Oct 26, 2014 | Issued |
Array
(
[id] => 16924047
[patent_doc_number] => 11045503
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-29
[patent_title] => Pharmaceutical composition for preventing, treating and curing rosacea, comprising snail slime, chamomile and propolis
[patent_app_type] => utility
[patent_app_number] => 15/510306
[patent_app_country] => US
[patent_app_date] => 2014-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3779
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15510306
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/510306 | Pharmaceutical composition for preventing, treating and curing rosacea, comprising snail slime, chamomile and propolis | Oct 16, 2014 | Issued |
Array
(
[id] => 18477131
[patent_doc_number] => 11690855
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-07-04
[patent_title] => Methods for treating lung infections and inflammation
[patent_app_type] => utility
[patent_app_number] => 14/515858
[patent_app_country] => US
[patent_app_date] => 2014-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 17136
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 133
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14515858
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/515858 | Methods for treating lung infections and inflammation | Oct 15, 2014 | Issued |
Array
(
[id] => 10755926
[patent_doc_number] => 20160102079
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-14
[patent_title] => 'ACETONE SOLVATE CRYSTALS OF TRITYL OMESARTAN MEDOXOMIL'
[patent_app_type] => utility
[patent_app_number] => 14/513984
[patent_app_country] => US
[patent_app_date] => 2014-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 4863
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14513984
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/513984 | ACETONE SOLVATE CRYSTALS OF TRITYL OMESARTAN MEDOXOMIL | Oct 13, 2014 | Abandoned |
Array
(
[id] => 10548463
[patent_doc_number] => 09273074
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-01
[patent_title] => 'Formylpyrrole-based heterocycles for nucleic acid attachment to supports'
[patent_app_type] => utility
[patent_app_number] => 14/512181
[patent_app_country] => US
[patent_app_date] => 2014-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13317
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14512181
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/512181 | Formylpyrrole-based heterocycles for nucleic acid attachment to supports | Oct 9, 2014 | Issued |
Array
(
[id] => 9989702
[patent_doc_number] => 09034906
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-19
[patent_title] => 'EP4 agonist'
[patent_app_type] => utility
[patent_app_number] => 14/498429
[patent_app_country] => US
[patent_app_date] => 2014-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 19219
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14498429
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/498429 | EP4 agonist | Sep 25, 2014 | Issued |
Array
(
[id] => 11121889
[patent_doc_number] => 20160318862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-03
[patent_title] => 'SYNTHESIS OF DELTA 12-PGJ3 AND RELATED COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/024427
[patent_app_country] => US
[patent_app_date] => 2014-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 101357
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15024427
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/024427 | SYNTHESIS OF DELTA 12-PGJ3 AND RELATED COMPOUNDS | Sep 24, 2014 | Abandoned |
Array
(
[id] => 10227089
[patent_doc_number] => 20150112082
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-23
[patent_title] => 'DIARYLHYDANTOIN COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 14/496973
[patent_app_country] => US
[patent_app_date] => 2014-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 43920
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14496973
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/496973 | DIARYLHYDANTOIN COMPOUNDS | Sep 24, 2014 | Abandoned |
Array
(
[id] => 10220354
[patent_doc_number] => 20150105348
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-16
[patent_title] => 'COMPOSITIONS AND METHODS FOR REDUCING LACTATE LEVELS'
[patent_app_type] => utility
[patent_app_number] => 14/491714
[patent_app_country] => US
[patent_app_date] => 2014-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 23532
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14491714
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/491714 | Compositions and methods for reducing lactate levels | Sep 18, 2014 | Issued |